Senior Financial Analyst
- Waltham, MA, USA
Kala Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary AMPPLIFY™ Drug Delivery Technology, with an initial focus on advancing treatments in ocular diseases. Kala’s first approved product is INVELTYS™, the first and only corticosteroid FDA-approved for BID treatment of post-operative inflammation and pain following ocular surgery. Kala’s lead pipeline product is KPI-121 0.25%, for the temporary relief of the signs and symptoms of dry eye disease, currently in Phase 3 clinical development. Kala anticipates filing for NDA with its current data set in the second half of 2018.
Senior Financial Analyst
Kala is an emerging pharmaceutical company on the verge of commercialization. We are seeking an experienced Senior Financial Analyst to assist with analytics and budget planning. This is an opportunity for the right individual to join Kala at a very exciting time. Come join an experienced and highly motivated team!
Key Responsibilities for this role will include:
Work with internal business partners to compile budgets and forecasts ensuring a strong attention to detail
Utilize understanding of budgets and forecasts to create high quality variance and trend analysis on a monthly, quarterly, annual basis
Ability to adapt to new processes and work to create processes where needed
Create models to analyze data for business plans and proposals for new or additional products and services
Prepare analytical reports to deliver to all levels of management
Provides analytical and other analysis to support budgets, as needed
Additional projects as assigned
Our ideal candidate will have:
BA/BS Accounting or Finance
5-7 years combined accounting, financial analysis & reporting experience
Experience analyzing financial statements required
CPA certification preferred but not required
Experience working in a pharmaceutical or healthcare setting
Strong attention to detail
Effective communication Skills
Proficient in excel
Able to work in a fast-paced environment while delivering a high-quality work product
Kala is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, with an initial focus on the treatment of eye diseases. Kala has applied the MPP technology to a corticosteroid designed for ocular applications, resulting in two lead product candidates. The product candidates are INVELTYSTM(KPI-121 1%) for the treatment of inflammation and pain following ocular surgery, for which we have submitted a NDA, and KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease, which is currently in Phase 3 clinical development.
All your information will be kept confidential according to EEO guidelines.